Dusa Pharmaceuticals ETF Forecast

Buy candidate since Jun 11, 2026 Gain 0.36%

The DUSA Pharmaceuticals Inc ETF price fell by -0.250% on the last day (Monday, 22nd Jun 2026) from $55.90 to $55.76. During the last trading day the ETF fluctuated 0.629% from a day low at $55.64 to a day high of $55.99. The price has risen in 5 of the last 10 days and is up by 1% over the past 2 weeks. Volume fell on the last day along with the ETF, which is actually a good sign as volume should follow the ETF. On the last day, the trading volume fell by -34 thousand shares and in total, 54 thousand shares were bought and sold for approximately $3.02 million.

The ETF lies in the middle of a narrow and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the ETF is expected to rise 10.87% during the next 3 months and, with a 90% probability hold a price between $60.93 and $63.79 at the end of this 3-month period.

DUSA Signals & Forecast

The DUSA Pharmaceuticals Inc ETF holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the ETF giving a positive forecast for the ETF. On further gains, the ETF will meet resistance from the short-term Moving Average at approximately $56.06. On a fall, the ETF will find some support from the long-term average at approximately $55.75. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, June 16, 2026, and so far it has fallen -1.47%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements. The ETF had a Golden Star Signal on Wednesday, April 01, 2026 in the long-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the ETF in question.

Support, Risk & Stop-loss for DUSA Pharmaceuticals Inc ETF

DUSA Pharmaceuticals Inc finds support from accumulated volume at $55.47 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the ETF tends to have very controlled movements and with good liquidity the risk is considered very low in this ETF. During the last day, the ETF moved $0.350 between high and low, or 0.629%. For the last week the ETF has had daily average volatility of 0.90%.

Our recommended stop-loss: $53.30 (-4.42%) (This ETF has very low daily movements and this gives very low risk. There is a sell signal from a pivot top found 3 days ago.)

Trading Expectations (DUSA) For The Upcoming Trading Day Of Tuesday 23rd

For the upcoming trading day on Tuesday, 23rd we expect DUSA Pharmaceuticals Inc to open at $55.80, and during the day (based on 14 day Average True Range), to move between $55.48 and $56.04, which gives a possible trading interval of +/-$0.560 (+/-1.01%) up or down from last closing price. If DUSA Pharmaceuticals Inc takes out the full calculated possible swing range there will be an estimated 1.01% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $55.85 (0.16%) than the support at $55.47 (0.52%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is DUSA Pharmaceuticals Inc ETF A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for DUSA Pharmaceuticals Inc ETF to perform well in the short-term. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this ETF since the last evaluation from a Strong Buy to a Buy candidate.

Current score: 2.219 Buy Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on June 23, 2026 - $55.80 ( 0.0658%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk